Inflammation and insulin resistance: New targets encourage new thinking
Abstract
Galectin‐3 and LTB4 are pro‐inflammatory molecules recently shown to directly cause insulin resistance in mouse and human cells. They are highly expressed in the obese state, and can be targeted both genetically and pharmacologically to improve insulin sensitivity in vivo. This expands on previous research showing that targeting inflammatory cytokines can be insulin sensitizing in animal models. However, translating these potential therapies into the human setting remains challenging. Here we review this latest research, and discuss how balancing their pleiotropic functions, the action of the microbiome, and the ability to identify relevant patient populations are vital considerations for successful anti‐inflammatory insulin sensitizing therapy.Keywords
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Institute of Diabetes and Digestive and Kidney Diseases (DK‐063491, DK‐09062, DK033651, DK074868)
- Merck
- National Natural Science Foundation of China (81622010)
- Chinese Academy of Medical Sciences
- Chinese Academy of Meteorological Sciences (2016‐I2M‐4‐001)
This publication has 76 references indexed in Scilit:
- Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastaseNature Medicine, 2012
- Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesityNature, 2012
- B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodiesNature Medicine, 2011
- Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parametersNature Medicine, 2009
- Normalization of obesity-associated insulin resistance through immunotherapyNature Medicine, 2009
- Ablation of CD11c-Positive Cells Normalizes Insulin Sensitivity in Obese Insulin Resistant AnimalsCell Metabolism, 2008
- Adipocyte-Derived Th2 Cytokines and Myeloid PPARδ Regulate Macrophage Polarization and Insulin SensitivityCell Metabolism, 2008
- Macrophage-specific PPARγ controls alternative activation and improves insulin resistanceNature, 2007
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006
- Effects of Etanercept in Patients With the Metabolic SyndromeArchives of internal medicine (1960), 2006